Since abnormal BMPR2 expression is a pathogenetic hallmark of PAH, we explored the potential role of SERCA2a in the regulation of BMPR2 expression and SMAD-signaling in hPASMCs. The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.